Infringement Analysis in Toronto.

A patent infringement analysis Toronto litigators can build a case on has to be scoped for where Canadian patent disputes are actually decided — overwhelmingly the Federal Court of Canada, the only court that can hear both infringement and validity and the only one whose orders run nationwide. Toronto is the heart of Canada’s economy: the Bay Street financial cluster, the Vector Institute deep-learning research hub that anchors roughly a third of the country’s AI patents, a large pharmaceutical and generics sector, and a deep advanced-manufacturing base across Southern Ontario. The patents asserted here read on fintech systems, machine-learning models, drug formulations and industrial processes, and each case turns on evidence that the accused product actually practises the claim. PerspireIP builds the claim charts and evidence-of-use that prove — or defeat — that link.

Where a patent infringement analysis Toronto case is decided

Patent law in Canada is federal, and that single constitutional fact shapes every enforcement strategy in Toronto. The vast majority of Canadian patent litigation is heard by the Federal Court of Canada, which has national jurisdiction over both infringement and validity and maintains a busy registry in Toronto at 180 Queen Street West. Its orders and any finding of invalidity take effect across the whole country, and its judges hear patent cases day in and day out, giving the bench a technical depth that draws counsel to it.

The critical distinction for a Toronto matter is what the provincial courts can and cannot do. The Ontario Superior Court of Justice has concurrent jurisdiction to hear a patent infringement claim, but it cannot invalidate a patent on an in rem basis — only the Federal Court can strike a patent from the register so that it is void against the world. A provincial court can, at most, decline to enforce a patent between the parties before it. That is why an accused party who wants the patent knocked out permanently, or a patentee who expects a validity attack, almost always ends up in the Federal Court.

Appeals from the Federal Court go to the Federal Court of Appeal, and from there, with leave, to the Supreme Court of Canada. Because infringement and any invalidity counterclaim are usually decided together in one Federal Court action, the evidence that the accused product reads on the claim has to be litigation-ready from the outset.

• Federal Court of Canada — the primary national forum; the only court that hears both infringement and validity and the only one that can invalidate a patent in rem, with a Toronto registry
• Ontario Superior Court of Justice — concurrent jurisdiction over infringement only; it cannot declare a patent invalid against the world
• Federal Court of Appeal — the appellate court for Federal Court patent judgments
• Supreme Court of Canada — the final court of appeal, on leave, in Ottawa

In-rem invalidity: the Federal Court advantage

Nowhere is the choice of forum sharper than on validity. In Canada a patent can be challenged either as a defence to infringement or head-on by an impeachment action seeking to have it declared invalid. Only the Federal Court can grant that in rem relief and order the Commissioner of Patents to strike or amend the record at CIPO. An Ontario Superior Court judge hearing an infringement claim can find the patent invalid only as between the parties — the patent survives against everyone else.

For an accused Toronto company this is decisive. If the goal is to clear a product for the whole Canadian market, the analysis must be built to support a Federal Court impeachment or an invalidity counterclaim, not merely a private non-infringement defence. That means pairing the infringement read with a rigorous prior-art and validity workup so the two run together in one action.

The substantive law also moved in the patentee’s favour. In AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36, the Supreme Court of Canada abolished the so-called “promise doctrine”, which had invalidated many patents for failing to deliver every promised use. Utility now requires only a “scintilla” of usefulness related to the subject matter, demonstrated or soundly predicted as of the Canadian filing date. A Toronto validity analysis has to be framed to the post-AstraZeneca standard, focusing invalidity attacks on anticipation, obviousness and sufficiency rather than on unmet promises.

PM(NOC): pharma patent litigation on the Federal Court’s exclusive track

Pharmaceuticals are one of Canada’s most litigated patent fields, and Toronto’s dense innovator and generics base makes the sector a constant presence in the local courts. Canadian pharma disputes run on a special linkage regime — the Patented Medicines (Notice of Compliance) Regulations, or PM(NOC) — that ties Health Canada’s approval of a generic or biosimilar to the innovator’s patents, much like the U.S. Hatch-Waxman system. These proceedings are heard exclusively in the Federal Court, never in a provincial court.

The regime changed fundamentally in September 2017, when amendments made under the Canada-EU trade agreement (CETA) converted PM(NOC) matters from summary applications into full actions with live infringement and validity findings, decided within a 24-month statutory stay and carrying proper appeal rights for both sides. In practice that means a generic filing its Notice of Allegation, and the innovator responding, each need a real, evidence-backed claim analysis from day one — not the thin paper record the old application track tolerated.

The asserted claims here read on formulations, salts and polymorphs, second-medical-use indications, dosage regimens and manufacturing processes. Whether you innovate or make generics, the case turns on whether a specific marketed product falls within the scope of a listed patent. That is exactly the question a claim chart is built to answer, and the compressed PM(NOC) timetable rewards having it ready before the litigation clock starts.

Toronto’s industries: what the asserted patents claim

Toronto’s litigation profile is written by the industries clustered around it. The city is Canada’s financial capital, and the Bay Street banks and fintech firms file and assert portfolios on payments, trading systems, fraud detection and connected financial software. It is also a world-class artificial-intelligence centre: the Vector Institute, founded in 2017, anchors a deep-learning research community, and the Toronto region accounts for roughly a third of all AI-related patents in Canada. Major banks such as RBC and TD built machine-learning labs alongside it, fusing the fintech and AI streams into a single, patent-dense ecosystem.

Software-driven and AI inventions raise a distinctly Canadian eligibility question. In Canada (Attorney General) v Benjamin Moore & Co, 2023 FCA 168, the Federal Court of Appeal struck down a lower-court test for patentable subject matter and sent computer-implemented claims back to CIPO to be assessed on their essential elements. For Toronto’s fintech and AI disputes, that keeps subject-matter eligibility live, so an infringement analysis of a software or model-based patent has to grapple with claim construction and eligibility together.

Around that core sit a substantial pharmaceutical and generics sector and a deep advanced-manufacturing base across Southern Ontario — automotive parts, industrial equipment and materials — generating process and composition patents where infringement often hides inside a plant. Whether the technology is a trading algorithm, a neural-network model, a polymorph or a factory process, the commercial question is identical: does the accused product or process actually fall within the scope of the asserted claim?

Discovery in Canada: building the evidence the claim chart needs

Canadian patent litigation gives both sides real tools to test an infringement theory, and a claim chart is what makes those tools productive. A Federal Court action moves through documentary discovery, in which each party produces the relevant documents in its possession, and oral discovery (examination for discovery), where a representative of the opposing party answers questions under oath and gives undertakings to follow up. For process and manufacturing patents, this is often where the decisive evidence about how the accused product is actually made comes to light.

Discovery is only as focused as the claim mapping behind it. An element-by-element chart tells you which document requests and which discovery questions matter, so you gather evidence that proves the specific limitations in dispute rather than fishing across the whole product. It also frames the expert evidence — on claim construction, infringement and validity — that ultimately decides the case at trial.

• Element-by-element claim charts mapping every limitation of the asserted claim to the accused product, process or software
• Evidence-of-use built from product teardowns, source-code and model analysis, technical datasheets, regulatory dossiers and public technical literature
• Discovery-ready targeting — document requests and examination topics driven by the specific claim elements in dispute
• Doctrine-of-equivalents analysis where the accused product is not a literal match, argued to Canadian claim-construction standards
• Non-infringement and validity positions for an accused Ontario company, paired for a Federal Court impeachment or counterclaim

How PerspireIP builds a Toronto infringement-analysis file

Every engagement follows the same disciplined path. We construct the claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product, process or system. For fintech and AI we work from software behaviour, model architecture and public technical documentation; for pharma from formulations, polymorph data and regulatory dossiers; for manufacturing from teardowns, process evidence and datasheets — charting infringement literally and, where needed, under the doctrine of equivalents.

• Claim construction and element-by-element charting to Canadian Patent Act and Federal Court standards
• Evidence-of-use assembly — teardowns, source-code and model review, datasheets, regulatory and public technical sources — dated and documented
• Infringement and non-infringement positions built for either side of a Federal Court or Ontario Superior Court dispute
• Validity and prior-art workups paired with the infringement read, scoped for an in rem impeachment or a PM(NOC) action
• Coordination with your Canadian trial counsel and, where the family is international, with parallel proceedings abroad

We work alongside your Canadian and international counsel as a specialist analysis partner, deliver to Federal Court and PM(NOC) deadlines, and keep every engagement confidential. Whether you are a Bay Street financial firm, an AI or fintech company, a pharmaceutical innovator or generic, or an Ontario manufacturer — enforcing a patent or clearing a path to market — we scale to fit, from a single claim chart to a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis Toronto project within one business day.

IP Landscape & Resources in Toronto

Key intellectual-property authorities and venues relevant to Toronto:

• CIPO (Canadian Intellectual Property Office) — the federal office that grants and maintains Canadian patents under the Patent Act and holds the patent register that only the Federal Court can order amended
• Federal Court of Canada — the national trial court that hears the bulk of Canadian patent infringement, impeachment and PM(NOC) cases, with a registry in Toronto
• Supreme Court of Canada — Canada's final court of appeal, whose 2017 AstraZeneca v Apotex decision abolished the promise doctrine and reset the utility standard
• WIPO (World Intellectual Property Organization) — administers the PCT and international IP framework under which many patents later enforced in Canada are filed

Request a Patent Infringement Analysis in Toronto

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions